Martin Childers

Mice with a disorder mimicking myotubular myopathy showed improvements in muscle strength and function in response to a myotubularin-based enzyme replacement therapy

posted on January 10, 2013 - 3:25pm
Update (Jan. 10, 2013): This story has been updated with additional information about MDA funding of this and related research projects.

Wake Forest researcher receives $369,365 for preclinical testing of gene transfer therapy for myotubular myopathy

posted on May 26, 2011 - 2:16pm
MDA’s translational research program has announced it is funding research into a potential treatment for the inherited muscle disorder X-linked myotubular myopathy (MTM). The grant of $369,365 grant to Wake Forest University professor Martin Childers will fund a three-year study of myotubularin gene transfer in mice and dogs that have an MTM-like disease.